Question · asked by 1 review

Cannabis‐based medicines vs placebo: Withdrawals due to adverse events

Population
adults with chronic neuropathic pain
Intervention
Cannabis‐based medicines
Comparison
placebo
Outcome
Withdrawals due to adverse events

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Cannabis‐based medicines vs placebo
Withdrawals due to adverse events · adults with chronic neuropathic pain
Cannabis‐based medicines for chronic neuropathic pain in adults (2018) · Cochrane Headline outcomes only
no estimate extracted13 studies · 1848 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Cannabis‐based medicines for chronic neuropathic pain in adults
2018 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.